CHRIS AMOS to Carcinoma, Squamous Cell
This is a "connection" page, showing publications CHRIS AMOS has written about Carcinoma, Squamous Cell.
Connection Strength
3.816
-
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma. Neoplasia. 2023 11; 45:100932.
Score: 0.549
-
Gene set selection via LASSO penalized regression (SLPR). Nucleic Acids Res. 2017 Jul 07; 45(12):e114.
Score: 0.356
-
The role of haplotype in 15q25.1 locus in lung cancer risk: results of scanning chromosome 15. Carcinogenesis. 2015 Nov; 36(11):1275-83.
Score: 0.313
-
BRCA2-branching out too? J Natl Cancer Inst. 2015 May; 107(5).
Score: 0.305
-
Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011 Oct; 32(10):1493-9.
Score: 0.236
-
Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci. Hum Mol Genet. 2025 Jul 03; 34(14):1227-1237.
Score: 0.155
-
Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden. Sci Rep. 2024 06 03; 14(1):12732.
Score: 0.144
-
Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. J Thorac Oncol. 2023 08; 18(8):1003-1016.
Score: 0.133
-
Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck. Int J Cancer. 2022 08 15; 151(4):553-564.
Score: 0.125
-
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 2021 03; 17(3):e1009254.
Score: 0.115
-
Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. Front Med. 2021 Apr; 15(2):275-291.
Score: 0.111
-
Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. Int J Epidemiol. 2019 06 01; 48(3):751-766.
Score: 0.102
-
Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2019 05; 28(5):935-942.
Score: 0.099
-
Statins associate with improved mortality among patients with certain histological subtypes of lung cancer. Lung Cancer. 2018 12; 126:89-96.
Score: 0.097
-
Genome-wide association study of familial lung cancer. Carcinogenesis. 2018 09 21; 39(9):1135-1140.
Score: 0.097
-
Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis. 2015 Nov; 36(11):1314-26.
Score: 0.078
-
Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus. Mol Carcinog. 2016 May; 55(5):953-63.
Score: 0.077
-
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014 Jul; 46(7):736-41.
Score: 0.072
-
Genetic variation in SIRT1 affects susceptibility of lung squamous cell carcinomas in former uranium miners from the Colorado plateau. Carcinogenesis. 2013 May; 34(5):1044-50.
Score: 0.065
-
Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese. PLoS Genet. 2013; 9(1):e1003190.
Score: 0.065
-
Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
Score: 0.065
-
Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov. 2012 Feb; 2(2):131-9.
Score: 0.060
-
Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet. 2011 Sep 15; 20(18):3718-24.
Score: 0.059
-
Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
Score: 0.053
-
Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
Score: 0.042
-
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006 Aug 10; 24(23):3789-98.
Score: 0.041
-
Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk. Nat Commun. 2024 10 04; 15(1):8629.
Score: 0.037
-
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
Score: 0.036
-
Segregation analysis of squamous cell carcinoma of the head and neck: evidence for a major gene determining risk. Ann Hum Genet. 1998 Nov; 62(Pt 6):505-10.
Score: 0.024
-
Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer. J Thorac Oncol. 2016 Jan; 11(1):52-61.
Score: 0.020
-
Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994 Nov 16; 86(22):1681-4.
Score: 0.019
-
Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013 Apr; 8(4):391-7.
Score: 0.017
-
Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 2011 Mar; 32(3):312-7.
Score: 0.014
-
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71.
Score: 0.014
-
Smoking-related genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med. 2008 Dec 01; 178(11):1164-72.
Score: 0.012
-
Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103.
Score: 0.005
-
A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res. 1995 Feb 01; 55(3):557-61.
Score: 0.005